http://orcid.org/0000-0001-6662-1334
Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Jing Jin, Xiangyan Ruan, Lin Hua & Alfred O. Mueck. (2023) Prevalence of metabolic syndrome and its components in Chinese women with premature ovarian insufficiency. Gynecological Endocrinology 39:1.
Read now
Read now
X. Ruan. (2023) Expert consensus on fertility preservation in hematopoietic stem cell transplantation in girls in China. Gynecological Endocrinology 39:1.
Read now
Read now
I. Lambrinoudaki & E. Armeni. (2023) Understanding of and clinical approach to cardiometabolic transition at the menopause. Climacteric 0:0, pages 1-7.
Read now
Read now
B.-K. Yoon. (2023) The impacts of menopausal hormone therapy on longer-term health consequences of ovarian hormone deficiency. Climacteric 26:3, pages 193-197.
Read now
Read now
Rossella E. Nappi, Lara Tiranini, Laura Cucinella, Ellis Martini, David Bosoni, Alessandra Righi, Chiara Cassani & Barbara Gardella. (2023) Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?. Expert Opinion on Pharmacotherapy 24:1, pages 135-143.
Read now
Read now
J. Mejia-Gomez, N. Phung, E. Philippopoulos, K. E. Murphy & W. Wolfman. (2021) The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review. Climacteric 24:6, pages 572-576.
Read now
Read now
Nick Panay. (2021) Progress in understanding and management of premature ovarian insufficiency. Climacteric 24:5, pages 423-424.
Read now
Read now
H. H. Nguyen, F. Milat & A. J. Vincent. (2021) New insights into the diagnosis and management of bone health in premature ovarian insufficiency. Climacteric 24:5, pages 481-490.
Read now
Read now
J. C. Stevenson, P. Collins, H. Hamoda, I. Lambrinoudaki, A. H. E. M. Maas, K. Maclaran & N. Panay. (2021) Cardiometabolic health in premature ovarian insufficiency. Climacteric 24:5, pages 474-480.
Read now
Read now
S. Kalra, A. Dhingra, S. K. Sharma & S. Bhattacharya. (2021) Sheehan’s syndrome as a mimic of premature ovarian insufficiency: need for advocacy. Climacteric 24:5, pages 526-526.
Read now
Read now
C. E. Upton, J. P. Daniels & M. C. Davies. (2021) Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy. Climacteric 24:5, pages 453-458.
Read now
Read now
S. M. Nelson & R. A. Anderson. (2021) Prediction of premature ovarian insufficiency: foolish fallacy or feasible foresight?. Climacteric 24:5, pages 438-443.
Read now
Read now
I. Lambrinoudaki, S. A. Paschou, M. A. Lumsden, S. Faubion, E. Makrakis, S. Kalantaridou & N. Panay. (2021) Premature ovarian insufficiency: a toolkit for the primary care physician. Climacteric 24:5, pages 425-437.
Read now
Read now
R. Rosario & R. A. Anderson. (2021) Novel approaches to fertility restoration in women with premature ovarian insufficiency. Climacteric 24:5, pages 491-497.
Read now
Read now
Rod Baber. (2020) What’s in a name? Eponyms, acronyms and POI. Climacteric 23:5, pages 421-422.
Read now
Read now
Articles from other publishers (87)
Cara Y. He, Danielle J. Lee, Kayla L. Foster & Catherine M. Gordon. (2024) Impact of ovarian insufficiency on bone health in childhood cancer survivors: Two cases. Bone 178, pages 116930.
Crossref
Crossref
Somaye Sadeghi, Nariman Mosaffa, Boxian Huang & Fahimeh Ramezani Tehrani. (2023) Protective role of stem cells in POI: Current status and mechanism of action, a review article. Heliyon, pages e23271.
Crossref
Crossref
Jiawen Ma, Zaiyang Zhang, Xin Yan, Cenglin Xu & Yizhou Zhang. (2023) Effect of Ningxin-Yishen Formula on D-galactose-induced Premature Ovarian Insufficiency Mice by Inhibiting p53. Clinical Complementary Medicine and Pharmacology 3:4, pages 100068.
Crossref
Crossref
Xuechun Ding, Shenmin Lv, Zhipeng Guo, Xiaowei Gong, Caiqin Wang, Xiaoyan Zhang & Kai Meng. (2023) Potential Therapeutic Options for Premature Ovarian Insufficiency: Experimental and Clinical Evidence. Reproductive Sciences 30:12, pages 3428-3442.
Crossref
Crossref
Sara Khaleghi, Farideh Eivazkhani, Somayeh Tavana, Ashraf Moini, Marefat Ghaffari Novin, Petkov Stoyan, Hamid Nazarian & Rouhollah Fathi. (2023) Follicular reconstruction and neo-oogenesis in xenotransplantation of human ovarian isolated cells derived from chemotherapy-induced POF patients. Journal of Biological Engineering 17:1.
Crossref
Crossref
Yu Yang, Xiangyan Ruan, Jiaojiao Cheng, Xin Xu & Alfred O. Mueck. (2023) Effects of different volumes of ovariectomy on fertility and offspring development of rats. Frontiers in Endocrinology 14.
Crossref
Crossref
Elinor Chelsom Vogt, Eirik Bratland, Siren Berland, Ragnhild Berentsen, Agnethe Lund, Sigridur Björnsdottir, Eystein Husebye & Marianne Øksnes. (2023) Improving diagnostic precision in primary ovarian insufficiency using comprehensive genetic and autoantibody testing. Human Reproduction.
Crossref
Crossref
Chan Su, Ruihong Zhang, Xiujuan Zhang, Mengxiao Lv, Xiang Liu, Kai Ao, Jing Hao & Yu-lan Mu. (2023) Dingkun Pill modulate ovarian function in chemotherapy-induced premature ovarian insufficiency mice by regulating PTEN/PI3K/AKT/FOXO3a signaling pathway. Journal of Ethnopharmacology 315, pages 116703.
Crossref
Crossref
Zi Xiu, Siling Tang, Peng Kong, Mengxuan Yan, Xue Tong, Xueping Liu, Xiao Liang, Rongxia Li & Yancang Duan. (2023) Zigui-Yichong-Fang protects against cyclophosphamide-induced premature ovarian insufficiency via the SIRT1/Foxo3a pathway. Journal of Ethnopharmacology 314, pages 116608.
Crossref
Crossref
Brian Kennedy, Deirdre Lundy, Rachel Mackey, Caoimhe Hartley & Karen Soffe. (2023) Novel method of breaking down barriers in the provision of menopause care in Ireland. Post Reproductive Health 29:3, pages 143-147.
Crossref
Crossref
Yaasir Mamoojee, Anna L. Mitchell & Richard Quinton. (2023) Risk of suboptimal hormone replacement therapy for young hypogonadal women and transgender women in the wake of the Joint BMS FSRH RCGP RCOG SfE and RCN Women's Health Forum safety alert. Clinical Endocrinology 99:3, pages 326-327.
Crossref
Crossref
Bengü Mutlu Sütcüoğlu & Melike Güler. (2023) Appropriateness of premature ovarian insufficiency recommendations provided by ChatGPT. Menopause.
Crossref
Crossref
Susan R. Davis, JoAnn Pinkerton, Nanette Santoro & Tommaso Simoncini. (2023) Menopause—Biology, consequences, supportive care, and therapeutic options. Cell 186:19, pages 4038-4058.
Crossref
Crossref
Yu-Qian Shi, Xi-Ting Zhu, Su-Na Zhang, Yi-Fu Ma, Yan-Hua Han, Yue Jiang & Yue-Hui Zhang. (2023) Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants. Frontiers in Endocrinology 14.
Crossref
Crossref
Longzhong Jia, Wenji Wang, Jing Liang, Shudong Niu, Yibo Wang, Jian Yang, Lingyu Li, Ge Wang, Xueqiang Xu, Lu Mu, Kaixin Cheng, Xuebing Yang, Yijing Wang, Haoshu Luo, Guoliang Xia, Yuwen Ke, Yan Zhang & Hua Zhang. (2023) Analyzing the cellular and molecular atlas of ovarian mesenchymal cells provides a strategy against female reproductive aging. Science China Life Sciences.
Crossref
Crossref
Tomáš Fait. (2023) Climacteric patient in office of general practitioner. Medicína pro praxi 20:3, pages 157-162.
Crossref
Crossref
Blazej Meczekalski, Olga Niwczyk, Gregory Bala & Anna Szeliga. (2023) Managing Early Onset Osteoporosis: The Impact of Premature Ovarian Insufficiency on Bone Health. Journal of Clinical Medicine 12:12, pages 4042.
Crossref
Crossref
Herjan J. T. Coelingh Bennink, Iman J. Schultz, Marcus Schmidt, V. Craig Jordan, Paula Briggs, Jan F. M. Egberts, Kristina Gemzell-Danielsson, Ludwig Kiesel, Kirsten Kluivers, Jan Krijgh, Tommaso Simoncini, Frank Z. Stanczyk & Robert D. Langer. (2023) Progesterone from ovulatory menstrual cycles is an important cause of breast cancer. Breast Cancer Research 25:1.
Crossref
Crossref
Jinhwan Lim, Toshihiro Shioda, Kelli F. Malott, Keiko Shioda, Junko Odajima, Kathleen N. Leon Parada, Julie Nguyen, Samantha Getze, Melody Lee, Jonathon Nguyen, Samantha Reshel Blakeley, Vienna Trinh, Hong-An Truong & Ulrike Luderer. (2023) Prenatal exposure to benzo[a]pyrene depletes ovarian reserve and masculinizes embryonic ovarian germ cell transcriptome transgenerationally. Scientific Reports 13:1.
Crossref
Crossref
Scott M Nelson, Susan R Davis, Sophia Kalantaridou, Mary Ann Lumsden, Nick Panay & Richard A Anderson. (2023) Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review. Human Reproduction Update 29:3, pages 327-346.
Crossref
Crossref
Nasim Eslami, Khadijeh Bahrehbar, Fereshteh Esfandiari, Faezeh Shekari, Seyedeh-Nafiseh Hassani, Abdoreza Nazari, Mohammad Pakzad & Hossein Baharvand. (2023) Regenerative potential of different extracellular vesicle subpopulations derived from clonal mesenchymal stem cells in a mouse model of chemotherapy-induced premature ovarian failure. Life Sciences 321, pages 121536.
Crossref
Crossref
Kaoru Kakinuma & Toshiyuki Kakinuma. (2023) Analysis of oxidative stress and antioxidative potential in premature ovarian insufficiency. World Journal of Clinical Cases 11:12, pages 2684-2693.
Crossref
Crossref
L. V. Tkachenko, I. A. Gritsenko, K. Yu. Tikhaeva, N. I. Sviridova, I. S. Gavrilova & V. A. Dolgova. (2023) Assessing an ovarian reserve and risk factors for premature ovarian failure as part of pre-abortion counseling for women under 40 planning to terminate own first pregnancy. Obstetrics, Gynecology and Reproduction 17:2, pages 244-251.
Crossref
Crossref
Xiao Guo, Yuemeng Zhu, Lu Guo, Yiwen Qi, Xiaocheng Liu, Jinhui Wang, Jiangtao Zhang, Linlin Cui, Yueyang Shi, Qichu Wang, Cenxi Liu, Guangxing Lu, Yilian Liu, Tao Li, Shangyu Hong, Yingying Qin, Xuelian Xiong, Hao Wu, Lin Huang, He Huang, Chao Gu, Bin Li & Jin Li. (2023)
BCAA
insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of
ROS
. EMBO Molecular Medicine 15:4.
Crossref
Crossref
Ekta Kapoor. (2023) Premature ovarian insufficiency. Current Opinion in Endocrine and Metabolic Research 28, pages 100435.
Crossref
Crossref
Simin Zafardoust, Somaieh Kazemnejad, Maryam Darzi, Mina Fathi-Kazerooni, Zahra Saffarian, Niloofar Khalili, Haleh Edalatkhah, Ebrahim Mirzadegan & Somayeh Khorasani. (2023) Intraovarian Administration of Autologous Menstrual Blood Derived-Mesenchymal Stromal Cells in Women with Premature Ovarian Failure. Archives of Medical Research 54:2, pages 135-144.
Crossref
Crossref
Silvia Federici, Marco Bonomi & Luca Persani. (2023) Management clinico e terapia sostitutiva dell’insufficienza ovarica primariaClinical management and replacement therapy of Primary Ovarian Insufficiency. L'Endocrinologo 24:1, pages 62-68.
Crossref
Crossref
Marco Torella, Maria Maddalena Marrapodi, Carlo Ronsini, Alessandro Ferdinando Ruffolo, Andrea Braga, Matteo Frigerio, Emanuele Amabile, Maria Giovanna Vastarella, Francesca Rossi & Gaetano Riemma. (2023) Risk of Premature Ovarian Insufficiency after Human Papilloma Virus Vaccination: A PRISMA Systematic Review and Meta-Analysis of Current Evidence. Vaccines 11:1, pages 140.
Crossref
Crossref
N.A. Babaeva, S.V. Yureneva, O.I. Aleshikova, O.V. Yakushevskaya & L.A. Ashrafyan. (2023) Possibilities of using hormone therapy in patients treated for malignant neoplasms of the vulva, vagina, and uterine cervix and body. Onkologiya. Zhurnal imeni P.A.Gertsena 12:1, pages 45.
Crossref
Crossref
Yen Suan Sin, Min Chen, Kim Sia Sng & Jianwei Zhang. (2023) Identifying the most effective Traditional Chinese Medicine treatment modalities for premature ovarian insufficiency: a systematic review and network meta-analysis. F1000Research 12, pages 450.
Crossref
Crossref
Giulia Paiva Oliveira Costa, Edson Santos Ferreira-Filho, Ricardo dos Santos Simoes, José Maria Soares-Junior, Edmund Chada Baracat & Gustavo Arantes Rosa Maciel. (2023) Impact of hormone therapy on the bone density of women with premature ovarian insufficiency: A systematic review. Maturitas 167, pages 105-112.
Crossref
Crossref
Svetlana Vujovic, Miomira Ivovic, Milina Tancic Gajic, Ljiljana Marina & Svetlana Dragojevic-Dikic. 2023. Amenorrhea. Amenorrhea
157
178
.
David Hessl, Hilary Rosselot, Robert Miller, Glenda Espinal, Jessica Famula, Stephanie L Sherman, Peter K Todd, Ana Maria Cabal Herrera, Karen Lipworth, Jonathan Cohen, Deborah A Hall, Maureen Leehey, Jim Grigsby, Jayne Dixon Weber, Sundus Alusi, Anne Wheeler, Melissa Raspa, Tamaro Hudson & Sonya K Sobrian. (2022) The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness. Journal of Medical Genetics 59:12, pages 1165-1170.
Crossref
Crossref
Sarah Cipriani, Elisa Maseroli & Linda Vignozzi. (2022) The role of androgens in sexual health and well-being after menopause: Unmet needs and opportunities. Current Opinion in Endocrine and Metabolic Research 27, pages 100405.
Crossref
Crossref
Rossella E Nappi. (2022) The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news. The Lancet Diabetes & Endocrinology 10:12, pages 832-834.
Crossref
Crossref
Liudmila V. Tkachenko, Irina A. Gritsenko, Ksenia Yu. Tikhaeva, Irina S. Gavrilova & Valeriia A. Dolgova. (2022) Modified pre-abortion counseling section. Bioethics 15:2, pages 59-65.
Crossref
Crossref
Ekta Kapoor, Stephanie S. Faubion, Liliana Gazzuola Rocca, Michelle M. Mielke, Carin Y. Smith & Walter A. Rocca. (2022) Trajectories of metabolic parameters after bilateral oophorectomy in premenopausal women. Maturitas 165, pages 38-46.
Crossref
Crossref
Rim Sakka, Fatma Abdelhedi, Hanen Sellami, Bruno Pichon, Yosra Lajmi, Mouna Mnif, Sahbi Kebaili, Rihab Derbel, Hassen Kamoun, Radhouane Gdoura, Anne Delbaere, Julie Desir, Marc Abramowicz, François Vialard, Jean-Michel Dupont & Leila Ammar-Keskes. (2022) An unusual familial Xp22.12 microduplication including EIF1AX: A novel candidate dosage-sensitive gene for premature ovarian insufficiency. European Journal of Medical Genetics 65:11, pages 104613.
Crossref
Crossref
Yan Cai, Qiong Zhang, Kewen Yu & Qiming Wang. (2022) Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency. BioMed Research International 2022, pages 1-7.
Crossref
Crossref
Eleni Armeni. (2022) Diagnostic challenges in suspected premature ovarian insufficiency. Case Reports in Women's Health 36, pages e00453.
Crossref
Crossref
Murylo Sforcin Batista, Yvonne Tsitsiou, Sabeera Dar, Giulia Ancillotti, Sonica Minhas & Natania Varshney. (2022) Life course reproductive dynamics associated with menopause in Ugandan women aged 40–49. American Journal of Human Biology 34:10.
Crossref
Crossref
Juan E. Blümel, Edward Mezones-Holguín, Peter Chedraui, Percy Soto-Becerra, Eugenio Arteaga & María S. Vallejo. (2022) Is premature ovarian insufficiency associated with mortality? A three-decade follow-up cohort. Maturitas 163, pages 82-87.
Crossref
Crossref
Irene Lambrinoudaki, Eleni Armeni, Dimitrios Goulis, Silvia Bretz, Iuliana Ceausu, Fatih Durmusoglu, Risto Erkkola, Ivan Fistonic, Marco Gambacciani, Marije Geukes, Haitham Hamoda, Caiomhe Hartley, Angelica Lindén Hirschberg, Blazej Meczekalski, Nicolas Mendoza, Alfred Mueck, Antonina Smetnik, Petra Stute, Mick van Trotsenburg & Margaret Rees. (2022) Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society. Maturitas 163, pages 1-14.
Crossref
Crossref
Graziella Borzì. (2022) Terapia ormonale sostitutiva e monitoraggio dell’insufficienza ovarica prematura. L'Endocrinologo 23:S1, pages 63-65.
Crossref
Crossref
Silvia Federici, Luca Persani & Marco Bonomi. (2022) Approccio diagnostico alla paziente con insufficienza ovarica primaria. L'Endocrinologo 23:S1, pages 59-62.
Crossref
Crossref
. (2022) The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 29:7, pages 767-794.
Crossref
Crossref
Ting Ding, Wei Yan, Ting Zhou, Wei Shen, Tian Wang, Milu Li, Su Zhou, Meng Wu, Jun Dai, Kecheng Huang, Jinjin Zhang, Jiang Chang & Shixuan Wang. (2022) Endocrine disrupting chemicals impact on ovarian aging: Evidence from epidemiological and experimental evidence. Environmental Pollution 305, pages 119269.
Crossref
Crossref
Lu Li, Bo Sun, Fang Wang, Yile Zhang & Yingpu Sun. (2022) Which Factors Are Associated With Reproductive Outcomes of DOR Patients in ART Cycles: An Eight-Year Retrospective Study. Frontiers in Endocrinology 13.
Crossref
Crossref
Brooke W. Bullington, Andrew Edmonds, Catalina Ramirez, Lisa Rahangdale, Genevieve Neal-Perry, Deborah Konkle-Parker, Deborah Jones Weiss, Caitlin Moran, Elizabeth Topper Golub, Helen Cejtin, Dominika Seidman, Seble Kassaye, Tracey E. Wilson, Anjali SharmaAdaora A. Adimora & Andrea K. Knittel. (2022) Premature and early menopause among US women with or at risk for HIV. Menopause 29:6, pages 741-747.
Crossref
Crossref
Caroline R. Gonçalves, Amanda S. Vasconcellos, Thaiana R. Rodrigues, Fabio V. Comin & Fernando M. Reis. (2022) Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis. Reproductive BioMedicine Online 44:6, pages 1143-1157.
Crossref
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2022) Optimizing menopausal hormone therapy: for treatment and prevention, menstrual regulation, and reduction of possible risks. Global Health Journal 6:2, pages 61-69.
Crossref
Crossref
Roger A Lobo & Anne Gompel. (2022) Management of menopause: a view towards prevention. The Lancet Diabetes & Endocrinology 10:6, pages 457-470.
Crossref
Crossref
Debra Holloway. (2022) The menopause: symptoms, treatments and implications for women’s health and well-being. Primary Health Care 32:3, pages 32-41.
Crossref
Crossref
Navira Samad, Hanh H. Nguyen, Hikaru Hashimura, Julie Pasco, Mark Kotowicz, Boyd J. Strauss, Peter R. Ebeling, Frances Milat & Amanda J. Vincent. (2022) Abnormal Trabecular Bone Score, Lower Bone Mineral Density and Lean Mass in Young Women With Premature Ovarian Insufficiency Are Prevented by Oestrogen Replacement. Frontiers in Endocrinology 13.
Crossref
Crossref
Richard A Anderson, David Cameron, Florian Clatot, Isabelle Demeestere, Matteo Lambertini, Scott M Nelson & Fedro Peccatori. (2022) Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Human Reproduction Update 28:3, pages 417-434.
Crossref
Crossref
Elinor Chelsom Vogt, Francisco Gómez Real, Eystein Sverre Husebye, Sigridur Björnsdottir, Bryndis Benediktsdottir, Randi Jacobsen Bertelsen, Pascal Demoly, Karl Anders Franklin, Leire Sainz de Aja Gallastegui, Francisco Javier Callejas González, Joachim Heinrich, Mathias Holm, Nils Oscar Jogi, Benedicte Leynaert, Eva Lindberg, Andrei Malinovschi, Jesús Martínez-Moratalla, Raúl Godoy Mayoral, Anna Oudin, Antonio Pereira-Vega, Chantal Raherison Semjen, Vivi Schlünssen, Kai Triebner & Marianne Øksnes. (2022) Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts. Endocrine Connections 11:5.
Crossref
Crossref
Rossella E. Nappi, Lara Tiranini, Ellis Martini, David Bosoni, Alessandra Righi & Laura Cucinella. (2022) Medical Treatment of Female Sexual Dysfunction. Urologic Clinics of North America 49:2, pages 299-307.
Crossref
Crossref
Zachary Nash, Bassel H. Al-Wattar & Melanie Davies. (2022) Bone and heart health in menopause. Best Practice & Research Clinical Obstetrics & Gynaecology 81, pages 61-68.
Crossref
Crossref
Fabio Sirchia, Elisa Giorgio, Laura Cucinella, Enza Maria Valente & Rossella E. Nappi. (2022) Biallelic mutations in PSMC3IP are associated with secondary amenorrhea: expanding the spectrum of premature ovarian insufficiency. Journal of Assisted Reproduction and Genetics 39:5, pages 1177-1181.
Crossref
Crossref
Xiaojun Kuang, Yongzhe Tang, Hong Xu, Min Ji & Dongmei Lai. (2022) The Evaluation of Ovarian Function Recovery Following Treatment of Primary Ovarian Insufficiency: A Systematic Review. Frontiers in Endocrinology 13.
Crossref
Crossref
Michał Kunicki, Jagoda Kruszewska, Jolanta Skórska, Hanna Laudy-Wiaderny, Marcin Wrona & Roman Smolarczyk. (2022) Does the Value of FSH Predict Severity of Metabolic Complications in Females with POI?. Journal of Clinical Medicine 11:7, pages 2024.
Crossref
Crossref
Richard A. Anderson, Tom W. Kelsey, Anne Perdrix, Nathalie Olympios, Orianne Duhamel, Matteo Lambertini & Florian Clatot. (2022) Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer. Breast Cancer Research and Treatment 192:2, pages 273-282.
Crossref
Crossref
L. V. Tkachenko, I. A. Gritsenko, K. Yu. Tikhaeva, N. I. Sviridova, I. S. Gavrilova & V. A. Dolgova. (2022) Assessment of risk factors and prediction of premature ovarian failure. Obstetrics, Gynecology and Reproduction 16:1, pages 73-80.
Crossref
Crossref
Hao Wang. (2022)
Linking
AI
supply chain strength to sustainable development and innovation: A country‐level analysis
. Expert Systems.
Crossref
Crossref
Min Yang, Li Jiang & Nan-nan Yao. (2022) Management of cardiovascular disease in women with premature ovarian insufficiency: critical quality appraisal of clinical guidelines and algorithm development. Menopause 29:2, pages 189-199.
Crossref
Crossref
Yan Liu, Xiaohe Zhu, Chunli Wu, Yan Lang, Wenjie Zhao & Yanmin Li. (2022) Melatonin protects against ovarian damage by inhibiting autophagy in granulosa cells in rats. Clinics 77, pages 100119.
Crossref
Crossref
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment
87
103
.
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment
105
116
.
Angelika V. Timofeeva, Ivan S. Fedorov, Maria A. Shamina, Vitaliy V. Chagovets, Nataliya P. Makarova, Elena A. Kalinina, Tatiana A. Nazarenko & Gennady T. Sukhikh. (2021) Clinical Relevance of Secreted Small Noncoding RNAs in an Embryo Implantation Potential Prediction at Morula and Blastocyst Development Stages. Life 11:12, pages 1328.
Crossref
Crossref
Jarika Vatrasresth, Ammarin Suwan & Krasean Panyakhamlerd. (2021) Effects of early estradiol valerate administration on bone turnover markers in surgically induced menopausal women. BMC Women's Health 21:1.
Crossref
Crossref
Rumana Rahman & Nick Panay. (2021) Diagnosis and management of premature ovarian insufficiency. Best Practice & Research Clinical Endocrinology & Metabolism 35:6, pages 101600.
Crossref
Crossref
Rossella E. Nappi, Laura Cucinella, Ellis Martini & Chiara Cassani. (2021) The role of hormone therapy in urogenital health after menopause. Best Practice & Research Clinical Endocrinology & Metabolism 35:6, pages 101595.
Crossref
Crossref
Serge Rozenberg, Victoria Di Pietrantonio, Jean Vandromme & Christine Gilles. (2021) Menopausal hormone therapy and breast cancer risk. Best Practice & Research Clinical Endocrinology & Metabolism 35:6, pages 101577.
Crossref
Crossref
Eleni Armeni, Stavroula A. Paschou, Dimitrios G. Goulis & Irene Lambrinoudaki. (2021) Hormone therapy regimens for managing the menopause and premature ovarian insufficiency. Best Practice & Research Clinical Endocrinology & Metabolism 35:6, pages 101561.
Crossref
Crossref
Sedigheh Bahmyari, Zeinab Jamali, Seyyed Hossein Khatami, Omid Vakili, Mahin Roozitalab, Amir Savardashtaki, Arezoo Solati, Pegah Mousavi, Zahra Shabaninejad, Sina Vakili, Hamid Behrouj, Hassan Ghasemi & Ahmad Movahedpour. (2021)
microRNAs
in female infertility: An overview
. Cell Biochemistry and Function 39:8, pages 955-969.
Crossref
Crossref
Edouard G Mills, Lisa Yang, Morten F Nielsen, Moustapha Kassem, Waljit S Dhillo & Alexander N Comninos. (2021) The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens. Endocrine Reviews 42:6, pages 691-719.
Crossref
Crossref
Lingdi Wang, Meifang Li, Jian Liu, Guangning Nie, Yang Li & Hongyan Yang. (2021) Protective effect of Huyang Yangkun Formula on ovarian function in premature ovarian insufficiency rats based on apoptotic mechanism. Journal of Ethnopharmacology 280, pages 114477.
Crossref
Crossref
Inês Mesquita, Margarida Lorigo & Elisa Cairrao. (2021) Update about the disrupting‐effects of phthalates on the human reproductive system. Molecular Reproduction and Development 88:10, pages 650-672.
Crossref
Crossref
. (2021) Resolution of The II International Menopause Expert Forum. REPRODUCTIVE ENDOCRINOLOGY:60, pages 77-84.
Crossref
Crossref
Valentina M. Denisova, Maria I. Yarmolinskaya & Karina A. Zakurayeva. (2021) Premature ovarian insufficiency: Genetic causes and treatment options. A literature review. Journal of obstetrics and women's diseases 70:3, pages 75-91.
Crossref
Crossref
Huajun Tang, Yao Liu, Yijin Fan & Chengzhi Li. (2021) Therapeutic Effects of Low-Intensity Pulsed Ultrasound on Premature Ovarian Insufficiency. Ultrasound in Medicine & Biology 47:8, pages 2377-2387.
Crossref
Crossref
Xiangyan Ruan, Jiaojiao Cheng, Juan Du, Fengyu Jin, Yanglu Li, Muqing Gu & Alfred O. Mueck. (2021) Prevention and treatment of iatrogenic premature ovarian insufficiency: interpretation of the first Chinese guideline on ovarian tissue cryopreservation and transplantation. Global Health Journal 5:2, pages 70-73.
Crossref
Crossref
G.I. Reznichenko & N.Y. Reznichenko. (2021) Search of ways to menopausal hormonal therapy and correction of bacterial vaginosis against the climacteric syndrome. REPRODUCTIVE ENDOCRINOLOGY:58, pages 73-78.
Crossref
Crossref
莎莎 张. (2021) Health Management of Premature Ovarian Insufficiency. Advances in Clinical Medicine 11:09, pages 4351-4355.
Crossref
Crossref
Irene Lambrinoudaki. (2021) Menopausal hormone therapy and breast cancer risk: All progestogens are not the same. Case Reports in Women's Health 29, pages e00270.
Crossref
Crossref
Hilde LöfqvistHilde Löfqvist. 2021. Hormontherapie in den Wechseljahren. Hormontherapie in den Wechseljahren
87
115
.
Richard A. Anderson & Scott M. Nelson. (2021) Anti-Müllerian Hormone in the Diagnosis and Prediction of Premature Ovarian Insufficiency. Seminars in Reproductive Medicine 38:04/05, pages 263-269.
Crossref
Crossref